The next move in the Biden Administration’s Cancer Moonshot is digital. The CancerX program, proposed in February, is a public-private partnership between the Digital Medicine Society (DiMe) and the Moffit Cancer Center that is focused on accelerating digital projects in oncology. Key initiatives include evidence generation, toolkit development, and best practice recommendations.
According to Phil Taylor, “The process starts with a pre-competitive evidence generation project, the first of which has already started with the formation of a multi-stakeholder group of experts “to assess, quantify, and enhance the impact of digital solutions on cancer care cost, access, and outcomes dimensions.””
To read more, click here.
(Source: pharma phorum, March 29th, 2023)